tsn

Successive mRNA COVID Jabs Induce T Cell Memory, But Characterized by Shifts in Clonal Dominance

 349
1 comment
Staff at TrialSite | Quality Journalism
Mar. 9, 2024, 10:00 p.m.

A Japan-based study suggests that T cell populations may go through significant change after each successive COVID mRNA vaccine or booster. Involving 38 healthcare workers at Nara Medical University who had received three doses of Pfizer-BioNTech mRNA BNT162b2,  along with dependence on TCR sequencing, this investigation reveals spike epitopes may emerge as immunodominant. Also, the investigators report intra-epitope shifts of vaccine-responding immune cell clonotypes.  Published in Cell Reports on March 7th, Hiroyasu Aoki and Satoshi Ueha, both from the Tokyo University of Science led the effort, led the study.  Does the output offer clarity necessary for improved next-generation vaccines? That is overcoming limitations such as durability or breadth challenges?

The Study

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News